Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 315.15 USD -7.05% Market Closed
Market Cap: 6.8B USD
Have any thoughts about
Madrigal Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 369.78 USD with a low forecast of 151.5 USD and a high forecast of 536.55 USD.

Lowest
Price Target
151.5 USD
52% Downside
Average
Price Target
369.78 USD
17% Upside
Highest
Price Target
536.55 USD
70% Upside

MDGL Last Price Targets
Madrigal Pharmaceuticals Inc

The latest public price target was made on May 29, 2024 by Yasmeen Rahimi from Piper Sandler , who expects MDGL stock to rise by 7% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Yasmeen Rahimi
Piper Sandler
336 USD
Upside 7%
5 months ago
May 29, 2024
Piper Sandler Reiterates Overweight Rating on Madrigal Pharmaceuticals (MDGL)
StreetInsider
Ed Acre
H.C. Wainwright
390 USD
Upside 24%
6 months ago
May 9, 2024
Madrigal Pharmaceuticals (MDGL) PT Lowered to $390 at H.C. Wainwright
StreetInsider
Liisa Bayko
Evercore ISI
405 USD
Upside 29%
7 months ago
Mar 19, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $405 at Evercore ISI, 'well positioned to execute on the launch of Rezdiffra'
StreetInsider
Akash Tewari
Jefferies
400 USD
Upside 27%
7 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $400 at Jefferies, 'label hit our bull case'
StreetInsider
Eliana Merle
UBS
410 USD
Upside 30%
7 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $410 at UBS
StreetInsider
Mayank Mamtani
B.Riley Financial
270 USD
Downside 14%
7 months ago
Mar 15, 2024
B.Riley Upgrades Madrigal Pharmaceuticals (MDGL) to Neutral
StreetInsider
Jonathan Wolleben
JMP Securities
397 USD
Upside 26%
7 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $397 at JMP Securities, ' We had strong conviction'
StreetInsider
Ed Acre
H.C. Wainwright
425 USD
Upside 35%
7 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $425 at H.C. Wainwright, 'Rezdiffra Achieves Landmark Approval'
StreetInsider
Show More Price Targets
Show Less Price Targets
Yasmeen Rahimi
Piper Sandler
Price Target 336 USD
Upside/Downside 7%
View Source
Ed Acre
H.C. Wainwright
Price Target 390 USD
Upside/Downside 24%
View Source
Liisa Bayko
Evercore ISI
Price Target 405 USD
Upside/Downside 29%
View Source
Akash Tewari
Jefferies
Price Target 400 USD
Upside/Downside 27%
View Source
Eliana Merle
UBS
Price Target 410 USD
Upside/Downside 30%
View Source
Mayank Mamtani
B.Riley Financial
Price Target 270 USD
Upside/Downside 14%
View Source
Jonathan Wolleben
JMP Securities
Price Target 397 USD
Upside/Downside 26%
View Source
Ed Acre
H.C. Wainwright
Price Target 425 USD
Upside/Downside 35%
View Source
Show More Price Targets
Show Less Price Targets
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
688105
Nanjing Vazyme Biotech Co Ltd
16% Downside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
14% Downside
NTLA
Intellia Therapeutics Inc
328% Upside
DNLI
Denali Therapeutics Inc
40% Upside
OPK
OPKO Health Inc
152% Upside
SGMT
Sagimet Biosciences Inc
452% Upside
GILD
Gilead Sciences Inc
4% Downside
LGVN
Longeveron Inc
300% Upside

Revenue
Forecast

Revenue Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDGL's stock price target?
Price Target
369.78 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 369.78 USD with a low forecast of 151.5 USD and a high forecast of 536.55 USD.

Back to Top